Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Objective: To assess and compare the value of whole-body MRI with FDG-PET for detecting bone marrow involvement in lymphoma.Methods: A total of 116 patients with newly diagnosed lymphoma prospectively underwent whole-body MRI and blind bone marrow biopsy (BMB) of the posterior iliac crest. Of 116 pa...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 23; no. 8; pp. 2271 - 2279
Autores principales: Adams, Hugo J A, Kwee, Thomas C, Vermoolen, Malou A, de Keizer, Bart, de Klerk, John M H, Adam, Judit A, Fijnheer, Rob, Kersten, Marie José, Stoker, Jaap, Nievelstein, Rutger A J
Formato: research Journal Article
Publicado: Springer Nature Aug2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104080259&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104080259
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Aug2013
      vid: 23
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104080259
        NLM23591618
        2012177803
        10.1007/s00330-013-2835-9
        NLM23591618
        104080259
      ppf: 2271
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.
      aug:
        au:
          Adams, Hugo J A
          Kwee, Thomas C
          Vermoolen, Malou A
          de Keizer, Bart
          de Klerk, John M H
          Adam, Judit A
          Fijnheer, Rob
          Kersten, Marie José
          Stoker, Jaap
          Nievelstein, Rutger A J
        affil: Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
      sug:
        subj:
          Bone Marrow Pathology
          Bone Marrow Neoplasms Pathology
          Fludeoxyglucose F 18 Diagnostic Use
          Lymphoma Pathology
          Magnetic Resonance Imaging Methods
          Tomography, Emission-Computed Methods
          Adolescence
          Adult
          Aged
          Aged, 80 and Over
          Biopsy
          Bone Marrow Neoplasms
          Female
          Human
          Lymphoma Diagnosis
          Male
          Middle Age
          Prospective Studies
          Radiopharmaceuticals Diagnostic Use
          Reproducibility of Results
          Sensitivity and Specificity
          Diagnostic Imaging
          Young Adult
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objective: To assess and compare the value of whole-body MRI with FDG-PET for detecting bone marrow involvement in lymphoma.Methods: A total of 116 patients with newly diagnosed lymphoma prospectively underwent whole-body MRI and blind bone marrow biopsy (BMB) of the posterior iliac crest. Of 116 patients, 80 also underwent FDG-PET. Patient-based sensitivities of whole-body MRI for detecting bone marrow involvement were calculated using BMB as reference standard and compared with FDG-PET in aggressive and indolent lymphomas separately.Results: Sensitivity of whole-body MRI in all lymphomas was 45.5 % [95 % confidence interval (CI): 29.8-62.0 %]. Sensitivity of whole-body MRI in aggressive lymphoma [88.9 % (95 % CI: 54.3-100 %)] was significantly higher (P = 0.0029) than that in indolent lymphoma [23.5 % (95 % CI: 9.1-47.8 %)]. Sensitivity of FDG-PET in aggressive lymphoma [83.3 % (95 % CI: 41.8-98.9 %)] was also significantly higher (P = 0.026) than that in indolent lymphoma [12.5 % (95 % CI: 0-49.2 %)]. There were no significant differences in sensitivity between whole-body MRI and FDG-PET (P = 1.00) CONCLUSION: Sensitivity of whole-body MRI for detecting lymphomatous bone marrow involvement is too low to (partially) replace BMB. Sensitivity of whole-body MRI is significantly higher in aggressive lymphoma than in indolent lymphoma and is equal to FDG-PET in both entities.Key Points: • Bone marrow involvement in lymphoma has prognostic and therapeutic implications. • Blind bone marrow biopsy (BMB) is standard for bone marrow assessment. • Neither whole-body MRI nor FDG-PET can yet replace BMB. • Both techniques have higher sensitivity in aggressive than in indolent lymphoma. • Both imaging techniques are complementary to BMB.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N